Navigation Links
Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
Date:11/11/2008

se. Gluten is an ingested protein found in wheat, barley and rye. Gluten is broken down into gliadin which can pass through the intestinal epithelial barrier during times of increased intestinal permeability. The ingestion of gluten causes an immune response which triggers an inflammatory reaction in the small intestine. This then causes damage to the villi in the small intestine and can lead to total villous atrophy in celiac disease. This results in varying symptoms such as fatigue, skin rash, anemia, fertility issues, joint pain, weight loss, pale sores inside the mouth, tooth discoloration or loss of enamel, depression, chronic diarrhea or constipation, gas and abdominal pain. The immunology and nutritional abnormalities in celiac disease can potentially result in long- term complications such as osteoporosis, refractory sprue, small intestinal cancer, and lymphoma.

Celiac disease is a growing public health concern, affecting approximately 3 million people in the United States and over 6.5 million people worldwide. The only current management of celiac disease is complete elimination of gluten from the diet, which can be very difficult to implement in practice. Additionally, the response to the gluten-free diet is poor in up to 30% of patients, and dietary nonadherence is the chief cause of persistent or recurrent symptoms.(1)

(1) Green, P, and Cellier, C, Review Article, Medical Progress, Celiac

Disease, N ENGL J MED 2007;357:1731-43

About "Larazotide Acetate"

Larazotide acetate is an experimental medicine and a tight junction regulator that acts locally by inhibiting the opening of tight junctions in epithelial cells lining the small intestine. In celiac disease, gluten crosses the epithelial barrier and stimulates the immune system, leading to cytokine release, gut inflammation, and opening of tight junctions. This leads to increased paracellular permeability, increased entry of gluten and the establishment of an i
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
2. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
3. InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer
4. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
5. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
6. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
7. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
8. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
9. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
10. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
11. PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  IBM (NYSE: IBM ... ( DESY ), a leading national research center in ... and storage of massive volumes of x-ray data. The ... on IBM software defined technology can handle more than ... and help scientists worldwide gain faster insights into the ...
(Date:8/21/2014)... MISSION, Kan. , Aug. 21, 2014 /PRNewswire-iReach/ ... Information Trust Alliance (HITRUST) under its Common Security ... ScriptPro,s Enterprise Security and Privacy Manager, "We appreciate ... the level of commitment that this certification signifies. ... compliant." ABOUT THE CSF CERTIFICATION PROCESS: ...
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3ScriptPro Achieves HITRUST Certification 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged ... of human viral diseases, today announced that two abstracts have ... the European Association for the Study of the Liver (EASL, ... can now be viewed at the EASL website at www.easl.eu. ...
... (Nasdaq: IDIX ) announced today that management will ... Stock Conference on Monday, March 14, 2011 at 12:00 p.m. ... California and at the Barclays Capital 2011 Global Healthcare Conference ... the Loews Miami Hotel, Florida. The live and ...
Cached Medicine Technology:Idenix Announces Data Presentations at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL) 2Idenix Announces Data Presentations at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL) 3
(Date:8/21/2014)... 2014 The new program, WellnessConnect ... Companies and builds on Accountable Health Solutions’ DiabetesConnect? ... combined with Accountable Health’s robust member engagement capabilities, ... and adds a custom incentive platform to help ... provider visits, HbA1c testing and more. ...
(Date:8/21/2014)... Sleep Apnea Doctors US is now offering complimentary ... with a convenient way to find new patients in their ... closer to finding remedies for sleep apnea . Many ... this sleep disorder , thus the majority of sleep ... to Sleep Apnea Doctors U.S., finding sleep doctors and receiving ...
(Date:8/21/2014)... Cary, NC (PRWEB) August 21, 2014 ... solutions for the health and human services markets, announced ... features and capabilities incorporating the Tin Can API. ... and their employees have the most advanced mobile learning ... greatest in adult learning tools and techniques,” says Jim ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... high-quality patient safety and efficacy endpoint data ... 2014 Regional Conference Series: Maximizing Product Value ... 1-day educational events enable biopharmaceutical developers to ... in interactive discussions on developing, implementing, and ...
(Date:8/21/2014)... be elicited by T-type calcium channels in the ... influxes of calcium. These channels enable thalamic reticular ... neurons to enter a hyper-excited state. , In ... and absence seizures, the researchers conducted an experiment ... targeting techniques to delete the T-type calcium channel ...
Breaking Medicine News(10 mins):Health News:Accountable Health Expands Diabetes Management Solutions to Address Gaps in Provider Care 2Health News:Accountable Health Expands Diabetes Management Solutions to Address Gaps in Provider Care 3Health News:Sleep Apnea Doctors US is Now Offering Complimentary Listings to Sleep Apnea Doctors Across the United States 2Health News:Relias Learning Announces Support for Tin Can API 2Health News:ERT Opens Registration for PROFICIENCY™ Regional Conference Series 2Health News:ERT Opens Registration for PROFICIENCY™ Regional Conference Series 3
... months , , TUESDAY, Feb. 10 (HealthDay News) -- Flu ... humidity levels are low, such as in the peak ... , A link between humidity and flu prevalence and ... been on relative humidity, not absolute humidity, according to ...
... 10 Zeus, Inc. is pleased to introduce ... live and accessible via http://www.zeusinc.com .With innovative ... user-friendly resource for comprehensive information about Zeus products ... conveniently organizes an extensive amount of information into ...
... SAN DIEGO, Feb. 10 Mpex Pharmaceuticals, Inc. ... million initial closing of a Series D financing ... include RiverVest Venture Partners, as well as existing ... and Adams Street Partners. These investors have made ...
... industry,s first ever patient-positioning pads developed specifically for ... by Sechrist Industries, the world leader in hyperbaric ... Pads(TM) are available in three multifunctional configurations -- ... give maximum versatility and flexibility in achieving optimum ...
... Feb. 10 Four western New York hospitals,using ... among health care providers reduced heart attack patient,deaths ... after patient discharge. , ... Strategies: Improved Treatment and Reduced Mortality in Patients,with ...
... Inc., a developer of innovative therapies in women,s health, ... health insurers with over 17 million members, is now ... (SUI) in non-pregnant women who are either not able ... According to Aetna,s updated policy posted on its website, ...
Cached Medicine News:Health News:Low Humidity Levels Help Flu Germs Spread 2Health News:Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million 2Health News:Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million 3Health News:Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million 4Health News:Sechrist Introduces Hyperbaric Industry's First Patient-Positioning Pads Designed for Use in Hyperbaric Chambers 2Health News:Sechrist Introduces Hyperbaric Industry's First Patient-Positioning Pads Designed for Use in Hyperbaric Chambers 3Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 2Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 3Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 4Health News:Aetna Now Covers Novasys Medical's Renessa(R) Treatment for Incontinence in Women 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: